EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Remnant Cholesterol Inflammatory Index and Its Association With All‐Cause Mortality Among General Population and Individuals With Cardiovascular–Kidney–Metabolic Syndrome Stages 0–3: Evidence From Two Nationwide Studies

Chen-Zhang Ou, Zhong-Qiang Liu, Yu-Jun Xiong iD, Shiqin Chen, Tian Lv iD, Jingjing Lou

Clinical Cardiology · 2026-04 · 49 (4)

DOI: 10.1002/clc.70297 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Cardiology, online erschienen am 13.04.2026. Verfasst von Chen-Zhang Ou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Jiangnan University Medical Center, Wuxi No.2 People's hospital, Wuxi, Jiangsu, China. Hauptthemen laut MEDLINE: Metabolic Syndrome, Cholesterol, Cardio-Renal Syndrome, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early identification of mortality risk in cardiovascular–kidney–metabolic (CKM) stages 0–3 remains challenging. The remnant cholesterol inflammatory index (RCII) has been associated with adverse outcomes, but its comparative prognostic performance in early CKM stages is unclear.

Methods

We analyzed data from two nationally representative cohorts, the U.S. National Health and Nutrition Examination Survey (NHANES) and the China Health and Retirement Longitudinal Study (CHARLS). RCII was compared with established metabolic indices for all‐cause mortality using Cox regression, receiver operating characteristic analyses, and restricted cubic splines, with stratification by CKM stages.

Results

Across both cohorts, higher RCII was consistently associated with increased all‐cause mortality in the general population and among individuals with CKM stages 0–3. RCII demonstrated superior discriminatory performance compared with other metabolic indices. These associations remained robust after multivariable adjustment and were driven primarily by individuals in the highest RCII category. In NHANES, RCII showed comparable associations with cardiovascular and non‐cardiovascular mortality.

Conclusion

RCII is a strong and independent predictor of all‐cause mortality across diverse populations and CKM stages 0–3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeCholesterolCardio-Renal SyndromeInflammationCardiovascular DiseasesHumansFemaleMaleUnited StatesNutrition SurveysBiomarkersMiddle AgedChinaCause of DeathRisk FactorsPrognosisRisk AssessmentSurvival RateAgedLongitudinal StudiesFollow-Up Studies

Stichwörter der Autor:innen

RCIIall‐cause mortalitycardiovascular–kidney–metabolic syndromemetabolic parameters

Substanzen

CholesterolBiomarkers

Autor:innen und Institutionen

  • Department of Urology, Jiangnan University Medical Center, Wuxi No.2 People's hospital, Wuxi, Jiangsu, China.
  • Department of Obstetrics and Gynecology, Xinyang Central Hospital, Xinyang, Henan, China.
  • Department of Gastroenterology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, P.R. China.
  • Department of Neurology, Yuhuan Second People's Hospital, Yuhuan, China.
  • Department of Neurology, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji, China.

ORCID-Profile: Yu-Jun Xiong, Tian Lv

Zitieren

APA

Ou, C. Z., Liu, Z. Q., Xiong, Y. J., Chen, S., Lv, T., & Lou, J. (2026). Remnant Cholesterol Inflammatory Index and Its Association With All‐Cause Mortality Among General Population and Individuals With Cardiovascular–Kidney–Metabolic Syndrome Stages 0–3: Evidence From Two Nationwide Studies. Clinical Cardiology, 49(4). https://doi.org/10.1002/clc.70297

Vancouver

Ou CZ, Liu ZQ, Xiong YJ, Chen S, Lv T, Lou J. Remnant Cholesterol Inflammatory Index and Its Association With All‐Cause Mortality Among General Population and Individuals With Cardiovascular–Kidney–Metabolic Syndrome Stages 0–3: Evidence From Two Nationwide Studies. Clinical Cardiology. 2026;49(4). doi:10.1002/clc.70297

BibTeX
@article{Ou2026,
  author = {Ou, Chen-Zhang and Liu, Zhong-Qiang and Xiong, Yu-Jun and Chen, Shiqin and Lv, Tian and Lou, Jingjing},
  title = {Remnant Cholesterol Inflammatory Index and Its Association With All‐Cause Mortality Among General Population and Individuals With Cardiovascular–Kidney–Metabolic Syndrome Stages 0–3: Evidence From Two Nationwide Studies},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {4},
  doi = {10.1002/clc.70297}
}
Kostenlos starten →